Sylvester Comprehensive Cancer Center

News

UM/Sylvester Licenses Patented Radiation Oncology Device to Treat Cervical Cancer

10.13.2004

Radiation oncologists at the University of Miami Sylvester Comprehensive Cancer Center have created a new device which promises far superior treatment of women with cervical cancer. The University of Miami Wolfson-Wu Vaginal Applicator allows physicians to deliver low-dose brachytherapy (targeted radiation therapy) with more precision, better response, much less patient discomfort and in less time than ever before. UM/Sylvester has just signed a licensing agreement with Bio-Nucleonics, Inc., a Miami pharmaceutical company, to develop and distribute the device, and is about to begin new clinical testing.

UM/Sylvester Opens Clinical Trial of Blood Pressure Medication to Treat Side Effects in Lung Cancer

10.12.2004

Radiation oncologists at the University of Miami Sylvester Comprehensive Cancer Center have opened a phase II clinical trial of captopril (Capoten), an angiotensin converting enzyme inhibitor which is an established blood pressure medication. The controlled trial will test the drug’s ability to help patients with lung cancer, the world’s leading cause of cancer deaths. Captopril works by inhibiting the angiotensin II enzyme which causes blood vessels to constrict. This relaxes the blood vessels throughout the body, helping blood flow more efficiently.